Hs-CRP與cTnI預(yù)測(cè)陣發(fā)性房顫射頻消融術(shù)后早期復(fù)發(fā)的臨床研究
[Abstract]:Background: atrial fibrillation (atrial fibrillation,AF) is one of the most common arrhythmias in clinic. The incidence of atrial fibrillation increases with age. Atrial fibrillation can induce heart failure and cerebral embolism. Atrial fibrillation leads to a five-fold increase in the risk of stroke, indicating that atrial fibrillation is not a purely cardiovascular disease. Therefore, reducing the incidence, hospitalization, disability and mortality of atrial fibrillation is the most important task in the treatment of atrial fibrillation at present. Long-term clinical observation, the effect of drug treatment of atrial fibrillation is not very ideal, atrial fibrillation is not easy to recover, especially chronic persistent atrial fibrillation, and drug treatment has many shortcomings such as side effects and adverse reactions. Through continuous exploration and research, catheter ablation in the treatment of atrial fibrillation has been recommended as a first-line treatment of paroxysmal atrial fibrillation. However, the recurrence rate of atrial fibrillation after radiofrequency ablation is still high, and the recurrence rate is about 25%. Risk factors associated with recurrence of AF after radiofrequency ablation included age, obesity, left atrial size, type of AF, duration of AF, BNP, inflammation, P-wave dispersion, whether or not it was associated with organic heart disease, and the use of antiarrhythmic drugs. It is particularly important to study the factors related to recurrence of atrial fibrillation after radiofrequency ablation. Objective: to investigate the relationship between serum Gao Min C reactive protein (hs-CRP) and troponin I (cTnI) and early recurrence after radiofrequency ablation of paroxysmal atrial fibrillation. Methods: from October 2014 to September 2016, 60 patients with paroxysmal atrial fibrillation (PAF) were selected from the Department of Cardiovascular Medicine of the first affiliated Hospital of Henan University of Science and Technology under the guidance of EnSite-NAVX non-contact mapping system. According to whether the patients recurred within three months after radiofrequency ablation (indicators: autonomic symptoms, 12-lead electrocardiogram and 24-hour ambulatory electrocardiogram, etc.), they were divided into successful treatment group (44 cases) and recurrent group (16 cases). Venous blood was collected 3 days after operation to determine the levels of hs-CRP and cTnI. The changes of hs-CRP and cTn I were compared between the successful group and the recurrent group before and after operation. Results: the peak levels of hs-CRP and cTn I in 60 patients with paroxysmal atrial fibrillation were significantly different before and after radiofrequency ablation (P0.05). There was no significant difference in hs-CRP and cTnI levels between the two groups before operation (P0.05). The peak value of hs-CRP and the difference of hsCRP concentration before and after operation were significantly different between the two groups (P0.05). There was no significant difference between the two groups in the peak value of cTn I and the difference of c Tn I concentration before and after operation (P0.05). Conclusion: the change of hs-CRP concentration may be related to the early recurrence after radiofrequency ablation of paroxysmal atrial fibrillation, but there is no significant correlation between cTnI and early recurrence after radiofrequency ablation of paroxysmal atrial fibrillation.
【學(xué)位授予單位】:河南科技大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R541.75
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 唐宏萍;辛輝;魏延津;;瑞舒伐他汀的劑量大小對(duì)房顫射頻消融術(shù)后復(fù)發(fā)的影響[J];山東醫(yī)學(xué)高等?茖W(xué)校學(xué)報(bào);2015年01期
2 胡曉鋒;張彭湃;王君;張睿;孫健;馮向飛;李毅剛;王群山;;ACE基因rs4353多態(tài)性與房顫消融術(shù)后復(fù)發(fā)關(guān)系[J];中國分子心臟病學(xué)雜志;2014年03期
3 屈園園;王松云;余鋰鐳;江洪;;P波離散度與陣發(fā)性心房顫動(dòng)患者射頻消融術(shù)后復(fù)發(fā)關(guān)系的Meta分析[J];中國循證心血管醫(yī)學(xué)雜志;2014年03期
4 黃啟祥;張偉明;;P波離散度預(yù)測(cè)陣發(fā)性心房顫動(dòng)射頻消融術(shù)后復(fù)發(fā)的價(jià)值[J];中外醫(yī)療;2014年08期
5 張曉玲;唐紅;;心房顫動(dòng)經(jīng)導(dǎo)管射頻消融術(shù)后復(fù)發(fā)的預(yù)測(cè)因素[J];中華老年多器官疾病雜志;2012年08期
6 韋葦;葛均波;朱文青;;肺靜脈結(jié)構(gòu)特點(diǎn)及左心房內(nèi)徑與心房顫動(dòng)經(jīng)導(dǎo)管射頻消融術(shù)后復(fù)發(fā)的關(guān)系[J];中華心律失常學(xué)雜志;2012年03期
7 常棟;褚振亮;高連君;楊延宗;;P波離散度對(duì)房顫消融術(shù)后預(yù)后的影響[J];臨床心電學(xué)雜志;2012年02期
8 金彥彥;張新勇;朱小玲;馬長生;龍德勇;;射頻導(dǎo)管消融治療陣發(fā)性心房顫動(dòng)患者的血漿B型利鈉肽水平[J];中華心血管病雜志;2012年01期
9 陳銀蓉;黃衛(wèi)斌;肖國勝;陳超;周法光;曾昭萍;溫紅梅;王焱;;左房容積與心房顫動(dòng)導(dǎo)管消融術(shù)后患者復(fù)發(fā)的關(guān)系[J];中國心臟起搏與心電生理雜志;2010年06期
10 陳俊;吳鋼;謝強(qiáng);;血清BNP濃度與肺靜脈消融術(shù)后房顫復(fù)發(fā)關(guān)系的研究[J];微循環(huán)學(xué)雜志;2010年02期
相關(guān)碩士學(xué)位論文 前1條
1 朱云婷;心房顫動(dòng)的治療進(jìn)展[D];山東大學(xué);2012年
,本文編號(hào):2308661
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2308661.html